These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 6391876)
1. Normalization of insulin sensitivity in type I diabetic subjects by physical training during insulin pump therapy. Yki-Järvinen H; DeFronzo RA; Koivisto VA Diabetes Care; 1984; 7(6):520-7. PubMed ID: 6391876 [TBL] [Abstract][Full Text] [Related]
3. Insulin sensitivity in newly diagnosed type 1 diabetics after ketoacidosis and after three months of insulin therapy. Yki-Järvinen H; Koivisto VA J Clin Endocrinol Metab; 1984 Sep; 59(3):371-8. PubMed ID: 6430945 [TBL] [Abstract][Full Text] [Related]
4. Insulin-mediated glucose disposal in type I diabetes: evidence for insulin resistance. Del Prato S; Nosadini R; Tiengo A; Tessari P; Avogaro A; Trevisan R; Valerio A; Muggeo M; Cobelli C; Toffolo G J Clin Endocrinol Metab; 1983 Nov; 57(5):904-10. PubMed ID: 6352727 [TBL] [Abstract][Full Text] [Related]
5. Continuous subcutaneous insulin infusion fails to correct impaired basal glucose metabolism and impaired insulin sensitivity of adipocytes from patients with type 1 (insulin-dependent) diabetes. Pedersen O; Hjøllund E; Beck-Nielsen H; Richelsen B; Sørensen NS Diabetes Res; 1986 Jan; 3(1):17-23. PubMed ID: 3514067 [TBL] [Abstract][Full Text] [Related]
6. The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus. Garvey WT; Olefsky JM; Griffin J; Hamman RF; Kolterman OG Diabetes; 1985 Mar; 34(3):222-34. PubMed ID: 3882489 [TBL] [Abstract][Full Text] [Related]
7. Insulin-mediated glucose disposal in type 1 (insulin-dependent) diabetic subjects treated by continuous subcutaneous or intraperitoneal insulin fusion. Beylot M; Khalfallah Y; Laville M; Sautot G; Dechaud H; Serusclat P; Berthezene F; Riou JP; Mornex R Diabete Metab; 1987; 13(4):450-6. PubMed ID: 3315766 [TBL] [Abstract][Full Text] [Related]
8. Site of insulin resistance in type 1 diabetes: insulin-mediated glucose disposal in vivo in relation to insulin binding and action in adipocytes in vitro. Yki-Järvinen H; Taskinen MR; Kiviluoto T; Hilden H; Helve E; Koivisto VA; Nikkilä EA J Clin Endocrinol Metab; 1984 Dec; 59(6):1183-92. PubMed ID: 6490795 [TBL] [Abstract][Full Text] [Related]
9. Postprandial blood glucose response to exercise in type I diabetes: comparison between pump and injection therapy. Koivisto VA; Tronier B Diabetes Care; 1983; 6(5):436-40. PubMed ID: 6400702 [TBL] [Abstract][Full Text] [Related]
10. In vivo and in vitro characterization of insulin resistance in three cases of lipoatrophic diabetes. Robert JJ; Magre J; Reynet C; Darmaun D; Picard J; Capeau J Diabete Metab; 1990; 16(3):240-7. PubMed ID: 2210020 [TBL] [Abstract][Full Text] [Related]
11. Differential effects of insulin therapy on hepatic and peripheral insulin sensitivity in Type 2 (non-insulin-dependent) diabetes. Nankervis A; Proietto J; Aitken P; Harewood M; Alford F Diabetologia; 1982 Oct; 23(4):320-5. PubMed ID: 6754516 [TBL] [Abstract][Full Text] [Related]
12. Metabolic response to fasting exercise in adolescent insulin-dependent diabetic subjects treated with continuous subcutaneous insulin infusion and intensive conventional therapy. Schiffrin A; Parikh S; Marliss EB; Desrosiers MM Diabetes Care; 1984; 7(3):255-60. PubMed ID: 6376018 [TBL] [Abstract][Full Text] [Related]
13. Insulin-based strategies to prevent hypoglycaemia during and after exercise in adult patients with type 1 diabetes on pump therapy: the DIABRASPORT randomized study. Franc S; Daoudi A; Pochat A; Petit MH; Randazzo C; Petit C; Duclos M; Penfornis A; Pussard E; Not D; Heyman E; Koukoui F; Simon C; Charpentier G Diabetes Obes Metab; 2015 Dec; 17(12):1150-7. PubMed ID: 26264812 [TBL] [Abstract][Full Text] [Related]
14. Effect of glyburide on glycemic control, insulin requirement, and glucose metabolism in insulin-treated diabetic patients. Simonson DC; Delprato S; Castellino P; Groop L; DeFronzo RA Diabetes; 1987 Feb; 36(2):136-46. PubMed ID: 3100365 [TBL] [Abstract][Full Text] [Related]
15. Impact of exercise training on insulin sensitivity, physical fitness, and muscle oxidative capacity in first-degree relatives of type 2 diabetic patients. Østergård T; Andersen JL; Nyholm B; Lund S; Nair KS; Saltin B; Schmitz O Am J Physiol Endocrinol Metab; 2006 May; 290(5):E998-1005. PubMed ID: 16352678 [TBL] [Abstract][Full Text] [Related]
16. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans. Saccà L; Sherwin R; Hendler R; Felig P J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832 [TBL] [Abstract][Full Text] [Related]
17. A comparison of troglitazone and metformin on insulin requirements in euglycemic intensively insulin-treated type 2 diabetic patients. Yu JG; Kruszynska YT; Mulford MI; Olefsky JM Diabetes; 1999 Dec; 48(12):2414-21. PubMed ID: 10580431 [TBL] [Abstract][Full Text] [Related]
18. Insulin receptor function and glycogen synthase activity in skeletal muscle biopsies from patients with insulin-dependent diabetes mellitus: effects of physical training. Bak JF; Jacobsen UK; Jørgensen FS; Pedersen O J Clin Endocrinol Metab; 1989 Jul; 69(1):158-64. PubMed ID: 2499587 [TBL] [Abstract][Full Text] [Related]
19. Comparison of the acute and long-term effects of exercise on glucose control in type I diabetes. Zinman B; Zuniga-Guajardo S; Kelly D Diabetes Care; 1984; 7(6):515-9. PubMed ID: 6439529 [TBL] [Abstract][Full Text] [Related]
20. Physical training may enhance beta-cell function in type 2 diabetes. Dela F; von Linstow ME; Mikines KJ; Galbo H Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E1024-31. PubMed ID: 15251867 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]